Source: Annual Congress 2006 - Epidemiology, diagnosis and treatment of multidrug-resistant tuberculosis (MDR-TB)
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. S. Zivkovic, M. M. Zivkovic, M. M. Radovic, S. M. Golubovic, L. Ristic, M. H. Rancic, T. N. Pejcic, I. J. Stankovic (Nis, Serbia And Montenegro). Effects of DOTS strategy on new confirmed tuberculosis. Eur Respir J 2006; 28: Suppl. 50, 3447

Member's Comments

No comment yet.

Related content which might interest you: The WHO-recommended strategy of tuberculosis control: the new vision of DOTS Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news? Year: 2007 Efficiency of the tuberculosis detection in the implantation of the DOTS program Source: Eur Respir J 2007; 30: Suppl. 51, 422s Year: 2007 Impact of applying the DOTS strategy on the TB endemic evolution in Bucharest Source: Eur Respir J 2007; 30: Suppl. 51, 422s Year: 2007 Drug resistance in previously treated patients of tuberculosis in pre DOTS and DOTS era and its implications Source: Annual Congress 2009 - Tuberculosis control Year: 2009 New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions Source: Eur Respir J 2002; 20: Suppl. 38, 368s Year: 2002 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 Population of bacteria in treatment of patients with tuberculosis by DOTS method Source: Eur Respir J 2001; 18: Suppl. 33, 175s Year: 2001 Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 New guidelines for screening for tuberculosis and latent tuberculosis infection pre-immunosuppressive therapy in the Netherlands: a targeted and stratified approach Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Evolution of the strategies for control and elimination of tuberculosis Source: Eur Respir Monogr 2018; 82: 36-61 Year: 2018 Surgical treatment of first found pulmonary tuberculosis at ineffectiveness of DOTS therapy Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions Year: 2011 Evolution of TB control and elimination strategies Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Effectiveness of implementation of lasolvan for comprehensive treatment of new cases with pulmonary TB Source: Eur Respir J 2007; 30: Suppl. 51, 658s Year: 2007 Effectiveness of implementation of lasolvan for comprehensive treatment of new cases with pulmonary TB Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis Year: 2008 Results of the treatment of relapses of tuberculosis by DOTS method Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001 Investing in a novel shorter treatment regimen for multidrug-resistant tuberculosis: to be repeated Source: Eur Respir J , 49 (3) 1700081; DOI: 10.1183/13993003.00081-2017 Year: 2017 Evaluation of new smear positive tuberculosis patients 5 years after initiation of treatment under a DOTS programme Source: Annual Congress 2010 - Tuberculosis epidemiology Year: 2010 The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis Source: Eur Respir J 2012; 39: 626-634 Year: 2012 Peculiarities in implementation of national tuberculosis program in patients with smear negative pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 190s Year: 2004